Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of ADACEL Polio as a Fifth Dose Booster in Children in Taiwan
2015-005190-21Phase 3
- Sponsor
- Sanofi
- Start
- Nov 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, single-arm trial of Adacel Polio in diphtheria, Tetanus, pertussis and 1 more, sponsored by Sanofi. Primary endpoint: Seroprotection to vaccine antigens one month after vaccination.
02
Drugs
Adacel Polio
03
Conditions
diphtheriaTetanuspertussispoliomyelitis
Beyond the preview
Go deeper on 2015-005190-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005190-21.